A new multi-institutional study, led by University Hospitals Connor Whole Health, found that adults with newly diagnosed low ...

Low back pain is one of the most common reasons adults seek medical care, and for many, it comes with the difficult question ...

Studies evaluate levothyroxine’s impact on cardiovascular disease risk in midlife and older women and in adults with ...

Topline data were announced from a pivotal phase 1/2 study evaluating AMT-130 in patients with Huntington disease.

Pivotal study met primary endpoint; high-dose AMT-130 demonstrated statistically significant 75% disease slowing at 36 months as measured by ...

Immunocompromised status may negatively affect survival outcomes in patients with bladder cancer, a study suggests.

The analysis revealed a mixed picture of psychosocial outcomes. Users showed modest but significant increases in affective ...

Qure N.V. (NASDAQ:QURE) on Wednesday released topline data from the pivotal Phase 1/2 study of AMT-130 for Huntington’s ...

AMT-130 has been granted Breakthrough Therapy designation and Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA.